Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Reiter's disease, hip (ICD Code: M02.35)
Summary
Reiter's disease, hip is a form of reactive arthritis affecting the hip joint, characterized by inflammation, pain, and stiffness. It typically develops following an infection, with symptoms appearing weeks to months after the initial illness. The condition involves immune-mediated joint damage, often accompanied by extra-articular manifestations such as eye inflammation or skin rashes. It is considered a post-infectious complication linked to immune responses triggered by the preceding infection.
Causes
Reiter's disease, hip is caused by the body's immune response to infections, most commonly bacterial infections of the genitourinary or gastrointestinal tract. The infection triggers an inflammatory reaction that can affect joints, even after the initial infection has resolved. The exact mechanism involves immune complex formation and systemic inflammation, though the precise pathways are not fully understood.
Risk Factors
- History of genitourinary or gastrointestinal infections, such as Chlamydia trachomatis or Salmonella.
- Pre-existing joint conditions or autoimmune tendencies.
- Genetic predisposition to inflammatory arthritis.
- Delayed or inadequate treatment of the initial infection.
Symptoms
- Joint pain, swelling, and stiffness in the hip.
- Reduced range of motion.
- Possible extra-articular symptoms like conjunctivitis, urethritis, or skin lesions.
Diagnosis
Diagnosis involves a combination of clinical evaluation, patient history (including recent infections), and physical examination. Laboratory tests may include inflammatory markers (e.g., ESR, CRP) and tests for infectious agents. Imaging (e.g., X-ray, MRI) can assess joint damage. Exclusion of other arthritic conditions is also part of the diagnostic process.
Treatment Options
Treatment focuses on managing symptoms and addressing the underlying infection. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain and inflammation. Physical therapy may help maintain joint function. Antibiotics may be prescribed if an active infection is present. In severe cases, corticosteroids or disease-modifying antirheumatic drugs (DMARDs) might be considered.
Prognosis and Follow-Up
Prognosis varies; symptoms often improve over time, but some patients may experience recurrent episodes or chronic joint issues. Regular follow-up is important to monitor joint function, manage symptoms, and address any complications. Early treatment can help reduce long-term damage.
Complications
Potential complications include chronic arthritis, joint deformity, or persistent pain. Extra-articular manifestations (e.g., eye or skin issues) may also persist. In rare cases, severe joint damage may require surgical intervention.
Lifestyle & Prevention
Preventive measures include prompt treatment of genitourinary or gastrointestinal infections. Maintaining good hygiene and safe sexual practices can reduce infection risk. Regular exercise and weight management may help preserve joint function. Avoiding smoking is also recommended, as it can worsen inflammatory conditions.
When to Seek Professional Help
Seek medical attention if you experience persistent hip pain, swelling, or stiffness, especially after a recent infection. Immediate care is needed for severe symptoms, such as inability to bear weight, high fever, or signs of eye or urinary tract involvement.
Tips for Medical Coders
Use M02.35 for Reiter's disease specifically affecting the hip. Ensure documentation supports the hip as the primary site of involvement and links the condition to a preceding infection. Include details of extra-articular manifestations or complications if present, as these may impact coding specificity. Verify that the code aligns with the clinical diagnosis and avoids overlap with other arthritic conditions.
M02.35 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.